Skip to main content
. 2021 May 18;11:665037. doi: 10.3389/fonc.2021.665037

Figure 1.

Figure 1

Bone marrow plasma levels of inflammatory soluble mediators in healthy subjects (CTRL; n = 17) and patients with essential thrombocythemia (ET, n = 28), polycythemia vera (PV, n = 19), and primary myelofibrosis (PMF, n = 16). The concentration of all the soluble mediators was determined using a Multiplex assay. Significant differences when p <0.05, Mann–Whitney test.